Afya Limited Acquires Além da Medicina

Afya Limited Acquires CardioPapers

April 5, 2022

Education

Afya Limited, through its subsidiary Afya Participações S.A., acquired 100% of CardioPapers, a Brazilian cardiology-focused medical education platform, for an enterprise value of R$35.0 million in cash plus an earn-out of up to R$15 million. The acquisition adds cardiology content and digital education capabilities to Afya's medical education ecosystem; CardioPapers reported ~7,000 students in 2021 and expected R$18.8 million gross revenue for 2022.

Afya Limited Acquires Unidom Participações S.A. (Unidompedro and Faculdade Dom Luiz)

July 1, 2024

Education

Afya Limited has closed the acquisition of 100% of Unidom Participações S.A., which includes Unidompedro and Faculdade Dom Luiz, expanding Afya's footprint in Bahia, Brazil. The deal adds 300 operational medical school seats and carries an aggregate purchase price of R$660.0 million (cash and installment payments tied to seat authorizations).

Afya Limited Acquires Glic

May 23, 2022

Healthcare Services

Afya Limited, through its subsidiary Afya Participações S.A., acquired 100% of Glic, a Brazil-based diabetes care and management app. The purchase (enterprise value R$22 million plus up to R$12 million in earn-outs) expands Afya’s digital services into the physician–patient relationship pillar and strengthens its healthtech ecosystem.

Afya Limited Acquires Faculdade Única de Contagem (FUNIC)

May 7, 2025

Education

Afya Limited closed the acquisition of 100% of Faculdade Masterclass Ltda. (FACULDADE ÚNICA DE CONTAGEM, “FUNIC”), a pre‑operational medical school in Contagem, Minas Gerais, Brazil. The aggregate purchase price is R$100 million (R$60m paid in cash on May 7, 2025; R$40m in three annual CDI‑adjusted installments) plus contingent consideration for up to 60 additional medical seats if approved by MEC within 36 months.

Afya Limited Acquires RX PRO

October 1, 2021

Marketing & Advertising

Afya Limited (Nasdaq: AFYA) has acquired 100% of RX PRO, a Brazil-based digital platform that connects physicians with pharmaceutical companies by delivering free samples and medical updates. The acquisition (enterprise value R$35.4 million) expands Afya's digital prescription capabilities and strengthens its physician-centric digital ecosystem, with part of the consideration in cash and Afya stock plus an earn-out tied to future revenue targets.

Lobe Sciences Ltd. Acquires Altemia & Company, LLC

August 30, 2023

Biotechnology

Lobe Sciences Ltd. signed an amendment to its share purchase agreement to acquire a 100% interest in Altemia & Company, LLC, including assets, know‑how, IP and commercial inventory related to Altemia, a medical food for sickle cell disease. The amended terms provide for the return and milestone-based reissuance of 76,000,000 Lobe common shares to the Altemia selling members upon achievement of specified development, delivery, commercial sale and tech-transfer milestones.